Fairness/ Second Opinion
The main objective of this module is to facilitate an investment decision by providing an objective, independent, and professional fairness or second opinion on the investment target, its ROI potential, and realization path.
We help our clients qualify most promising investment opportunities within the MedTech and Biotech sectors.
We perform market insights and data driven, fact based, independent, and objective due diligence analyses to inform and instill confidence into our clients’ investment decisions.
We provide in-depth or high-level fairness/ second opinion due diligence in any or all of the following areas:
Overall investing recommendation
Commercial due diligence
Valuation due diligence
Regulatory due diligence
Design & technology due diligence
Innovation pipeline due diligence